BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3891168)

  • 1. Glomerular deposition of immune complexes prepared with monomeric or polymeric IgA.
    Rifai A; Millard K
    Clin Exp Immunol; 1985 May; 60(2):363-8. PubMed ID: 3891168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.
    Chen A; Wong SS; Rifai A
    Am J Pathol; 1988 Jan; 130(1):216-22. PubMed ID: 3276211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance kinetics, tissue localization and fate of IgA-anti-idiotype complexes.
    Rifai A; Wu CG
    Immunology; 1990 Apr; 69(4):610-5. PubMed ID: 2335380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA.
    Rifai A; Mannik M
    J Immunol; 1983 Apr; 130(4):1826-32. PubMed ID: 6833754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial transcytosis of monomeric IgA and IgG cross-linked through antigen to polymeric IgA. A role for monomeric antibodies in the mucosal immune system.
    Kaetzel CS; Robinson JK; Lamm ME
    J Immunol; 1994 Jan; 152(1):72-6. PubMed ID: 8254208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates.
    Sancho J; González E; Rivera F; Escanero JF; Egido J
    Immunology; 1984 May; 52(1):161-7. PubMed ID: 6715019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of nephritogenic IgA immune complexes.
    Rifai A
    Am J Kidney Dis; 1988 Nov; 12(5):402-5. PubMed ID: 3189324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in experimental IgA nephropathy: an antigen-mediated process.
    Rifai A; Chen A; Imai H
    Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA.
    Renegar KB; Jackson GD; Mestecky J
    J Immunol; 1998 Feb; 160(3):1219-23. PubMed ID: 9570537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute experimental glomerulonephritis induced by the glomerular deposition of circulating polymeric IgA-concanavalin A complexes].
    Davin JC; Dechenne C; Mahieu PR
    Nephrologie; 1989; 10(3):151-5. PubMed ID: 2691913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hepatocytes in the uptake of IgA and IgA-containing immune complexes in mice.
    Phillips JO; Komiyama K; Epps JM; Russell MW; Mestecky J
    Mol Immunol; 1988 Sep; 25(9):873-9. PubMed ID: 3062387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of complement activation by human IgA immune complexes.
    Imai H; Chen A; Wyatt RJ; Rifai A
    Clin Exp Immunol; 1988 Sep; 73(3):479-83. PubMed ID: 3061690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V; Esparza AR; Cavallo T; Rifai A
    Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA molecular form--pathophysiology correlates: immune complex formation and glomerular deposition.
    Rifai A; Chen A; Imai H; Millard K
    Adv Exp Med Biol; 1987; 216B():1515-22. PubMed ID: 3425443
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed clearance of specific polymeric IgA immune complexes in patients with IgA nephropathy.
    Sancho J; Egido J; Rivera F; Hernando L
    Proc Eur Dial Transplant Assoc; 1983; 20():617-22. PubMed ID: 6657681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.
    Leung JC; Tang SC; Chan LY; Tsang AW; Lan HY; Lai KN
    Nephrol Dial Transplant; 2003 Jan; 18(1):36-45. PubMed ID: 12480958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of polyclonal and polymeric IgA in a murine model of mesangial proliferative glomerulonephritis with IgA deposition.
    Muso E; Yoshida H; Takeuchi E; Shimada T; Yashiro M; Sugiyama T; Kawai C
    Clin Exp Immunol; 1991 Jun; 84(3):459-65. PubMed ID: 2044226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.